Waters (WAT) Net Income towards Common Stockholders (2009 - 2026)
Waters (WAT) recorded quarterly Net Income towards Common Stockholders of -$72.0 million in Q2 2026, down 131.97% quarter-over-quarter from $225.2 million in Q4 2025, and down 159.32% on a YoY basis from $121.4 million in Q2 2025.
Waters (WAT) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Waters' Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at -$72.0 million for Q2 2026.
- In Q2 2026, Net Income towards Common Stockholders fell 159.32% year-over-year to -$72.0 million; the TTM figure through Apr 2026 stood at $449.2 million (down 31.62% YoY), while the FY2025 annual figure was $642.6 million, up 0.75% from the prior year.
- Net Income towards Common Stockholders was -$72.0 million for Q2 2026 at Waters, down from $225.2 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $231.4 million in Q4 2024 to a low of -$72.0 million in Q2 2026.
- Historically, Net Income towards Common Stockholders has averaged $150.5 million across 5 years, with a median of $150.6 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Net Income towards Common Stockholders gained 20.03% in 2024, then slumped 159.32% in 2026.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $227.1 million in 2022, then dropped by 4.78% to $216.2 million in 2023, then grew by 7.03% to $231.4 million in 2024, then dropped by 2.67% to $225.2 million in 2025, then slumped by 131.97% to -$72.0 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$72.0 million (Q2 2026), $225.2 million (Q4 2025), and $148.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 141.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -85.11 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn | -40.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -72.00 Mn |
| Dec 31, 2025 | 225.21 Mn |
| Sep 27, 2025 | 148.92 Mn |
| Jun 28, 2025 | 147.11 Mn |
| Mar 29, 2025 | 121.38 Mn |
| Dec 31, 2024 | 231.40 Mn |
| Sep 28, 2024 | 161.50 Mn |
| Jun 29, 2024 | 142.74 Mn |
| Mar 30, 2024 | 102.20 Mn |
| Dec 31, 2023 | 216.21 Mn |
| Sep 30, 2023 | 134.55 Mn |
| Jun 30, 2023 | 150.55 Mn |
| Mar 31, 2023 | 140.92 Mn |
| Dec 31, 2022 | 227.06 Mn |
| Sep 30, 2022 | 156.00 Mn |
| Jun 30, 2022 | 164.86 Mn |
| Mar 31, 2022 | 159.83 Mn |
| Dec 31, 2021 | 216.24 Mn |
| Sep 30, 2021 | 161.19 Mn |
| Jun 30, 2021 | 167.29 Mn |